Funded Tech Companies

Mozart Therapeutics

Mozart Therapeutics is a biopharmaceutical tech company, located in Seattle. Venture capital investment was provided by AbbVie Biotech Ventures, Eli Lilly and Company and Pfizer Venture Investments.

Company Overview

Contact Information

Company Background Information

Overview

Mozart Therapeutics is focused on developing disease-modifying therapies for autoimmune and inflammatory diseases that work by targeting a novel regulatory immune pathway. The therapeutic focus of Mozart's lead program is autoimmune mediated gastro-intestinal disorders. The company is headquartered in Seattle, WA.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

6/7/2023

Financing History

Management Team

Title

Name

Email & Social

Chairman

Steven Gillis

        

Chief Executive Officer

Katie Fanning

        

Chief Scientific Officer

Kristine Swiderek

        

Vice President

Courtney Crane

        

Company Investors

• AbbVie Biotech Ventures
• Eli Lilly and Company (Julie Gilmore)
• Pfizer Venture Investments
• Leaps by Bayer (Lucio Iannone)
• Alexandria Venture Investments
• Ono Venture Investment
• Altitude Life Science Ventures
• UPMC Enterprises
• Sofinnova Partners
• MRL Ventures (Peter Dudek)
• Arch Venture Partners (Steve Gillis)
• Sofinnova Ventures (Henrijette Richter)

Browse more funded tech companies:

Mozart Data | Mozes

Share this article

About Our Venture Capital Transactions Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary